NCT06958627
- Conditions
- HER2 Positive Breast Cancer, Pyrotinib Treatment
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying Pyrotinib Treatment. Study availability and eligibility vary by location and protocol.
NCT06958627